共 50 条
- [1] COMPARISON OF EPIGENETIC VERSUS INTENSIVE CHEMOTHERAPY FOR NEWLY DIAGNOSED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS ≥60 YEARS OLDJOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S55 - S56Gupta, NehaGandhi, ShipraMiller, AustinFord, Laurie A.Griffiths, Elizabeth A.Thompson, James E.Wetzler, MeirWang, Eunice
- [2] Comparison Of Epigenetic Versus Intensive Chemotherapy For Newly Diagnosed Acute Myeloid Leukemia Patients ≥60 Years Old: The Roswell Park ExperienceBLOOD, 2013, 122 (21)Gupta, NehaGandhi, ShipraMiller, AustinFord, Laurie A.Griffiths, Elizabeth A.Thompson, James E.Wetzler, MeirWang, Eunice S.
- [3] Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients 60 years oldAMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (07) : 639 - 646Gupta, NehaMiller, AustinGandhi, ShipraFord, Laurie A.Vigil, Carlos E.Griffiths, Elizabeth A.Thompson, James E.Wetzler, MeirWang, Eunice S.
- [4] Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid LeukemiaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05): : 290 - +Choi, Eun-JiLee, Je-HwanPark, Han-SeungLee, Jung-HeeSeol, MieeLee, Young-ShinKang, Young-AhJeon, MijinWoo, Ji MinLee, Kyoo-Hyung
- [5] Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid LeukemiaBLOOD, 2018, 132Choi, Eun-JiLee, Je-HwanPark, Han-SeungLee, Jung-HeeSeol, MieeLee, Young-ShinKang, Young-AhJeon, MijinWoo, Ji MinLee, Kyoo Hyung
- [6] EPIGENETIC THERAPY IS ASSOCIATED WITH SIMILAR SURVIVAL COMPARED WITH INTENSIVE CHEMOTHERAPY IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIAHAEMATOLOGICA, 2012, 97 : 446 - 446Quintas-Cardama, A.Cortes, J.Liu-Dumlao, T.Ravandi, F.Brandt, M.Faderl, S.Pierce, S.Borthakur, G.Garcia-Manero, G.Kantarjian, H.
- [7] Risk Stratification of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive ChemotherapyBLOOD, 2021, 138Gardeney, HeleneDiaz, Jose Miguel TorregrosaBasle, CarolineCayssials, EmilieBouyer, SabrinaMoya, NielsGruchet, CecileSabirou, FlorenceBobin, ArthurLevy, AnthonyNsiala, LalyCailly, LauraVonfeld, MathildeDesmier, DeborahLeleu, XavierHernanz, Maria Pilar Gallego
- [8] 5-Azacytidine Versus Intensive Chemotherapy or BSC in Elderly (>60 years) Acute Myeloid Leukemia Patients. A Retrospective AnalysisBLOOD, 2011, 118 (21) : 1121 - 1122Serrano, Jose-Finade la Fuente, AdolfoBergua, JuanFalantes, JoseEusebio, Martin-ChaconJuan Antonio, LopezMartinez-Losada, M. C.Casano, J.Romero, AntonioElena, PrietoMendez, G.Tabares, S.Francisco Tomas, JoseJoaquin, Sanchez-GarciaAntonio, Torres
- [9] Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid LeukemiaONCOLOGY RESEARCH, 2014, 22 (02) : 85 - 92Ross, KellyGillespie-Twardy, Amanda L.Agha, MounzerRaptis, AnastasiosHou, Jing-ZhouFarah, RaficRedner, Robert L.Im, AnnieDuggal, ShrinaDing, FeiLin, YanBoyiadzis, Michael
- [10] Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemiaBLOOD, 2012, 120 (24) : 4840 - 4845Quintas-Cardama, AlfonsoRavandi, FarhadLiu-Dumlao, TheresaBrandt, MarkFaderl, StefanPierce, SherryBorthakur, GautamGarcia-Manero, GuillermoCortes, JorgeKantarjian, Hagop